Emir Çapkınoğlu

9PUBLICATIONS
25CO-AUTHORS
ChemotherapyMolecular targetsMedical biochemistry - inorganic elements and compoundsCancer therapy (excl. chemotherapy and radiation therapy)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 04, 2026
The Effect of Cannabidiol on Cancer-Pathway Genes in Doxorubicin-Sensitive and Resistant Breast Cancer Cells.

|May 04, 2026
Transcriptional Reprogramming of Cancer Metabolism: Tricholoma terreum Inhibits Nucleotide Biosynthesis and Energy Flux in MCF-7 Cells by Downregulating DHFR, TK1, and ENO1.

|Mar 28, 2026
From Phytochemical Characterization to Energy Metabolism-Driven Molecular Responses: The Anticancer Potential of Lactarius deliciosus (L.) Gray in Breast Cancer Cells.

Levent Gülüm, Emrah Güler, Emir Çapkınoğlu

|Mar 24, 2026
Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 1: Locoregional Therapy, Pathology, Radiology.

Elif Şenocak Taşçı, Halil Kara, Emir Çapkınoğlu

|Dec 30, 2025
Evaluation of Anticancer Potential of Ganoderma lucidum on MCF-7 Breast Cancer Cells Through Genetic Transcription of Energy Metabolism.

Levent Gülüm, Emrah Güler, Emir Çapkınoğlu

|Nov 27, 2025
Anticancer and Immunomodulatory Effects of a Thiazolyl Benzodiazepine Targeting HSP90 in ER+ Breast Cancer.

Kubra Acikalin Coskun, Lutfi Tutar, Kezban Uçar Çifci

Pageof 2

Frequent Collaborators

5 joint publications

Yusuf Tutar

4 joint publications

Ayşe Büşranur Çelik

3 joint publications

Emrah Güler

2 joint publications

Levent Gülüm